STVN Earnings Date: Nov 3, 2026 (Estimated) — Stevanato Group S.p.A.
NYSE · Healthcare · Medical Instruments & Supplies
Updated
When is STVN's next earnings date?
Stevanato Group S.p.A. (STVN) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.18 on revenue of $363.3M.
How did STVN do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Stevanato Group S.p.A. posted EPS of $0.16 versus the $0.14 estimate, a beat of 15.7%. Revenue was $351.1M against a $351.4M estimate. The stock's 1-day post-earnings move was -4.6%.
How much does STVN stock move after earnings?
STVN beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.9% (up or down) in the day after earnings.
About Stevanato Group S.p.A.
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | 0.14 | 0.16 | +15.71% | $351.1M | ✅ Beat | -4.57% | -0.05% | +0.58% |
| 2026-05-07 | Q1 2026 | 0.12 | 0.13 | +8.33% | $320.4M | ✅ Beat | -5.12% | -6.02% | -2.85% |
| 2026-03-04 | Q4 2025 | 0.20 | 0.21 | +5.00% | $403.4M | ✅ Beat | +18.79% | +2.31% | -6.67% |
| 2025-11-06 | Q3 2025 | 0.14 | 0.16 | +14.29% | $354.5M | ✅ Beat | -2.37% | -5.25% | -11.55% |
| 2025-08-05 | Q2 2025 | 0.11 | 0.13 | +18.18% | $317.5M | ✅ Beat | -9.72% | -14.58% | -8.90% |
| 2025-03-06 | Q4 2024 | 0.19 | 0.20 | +5.26% | $352.8M | ✅ Beat | +8.59% | +5.59% | +5.43% |
| 2024-11-05 | Q3 2024 | 0.14 | 0.13 | -7.14% | $305.4M | ❌ Miss | +16.07% | +9.85% | +3.78% |
| 2024-08-06 | Q2 2024 | 0.11 | 0.10 | -9.09% | $279.5M | ❌ Miss | +5.78% | +6.04% | +14.87% |
Showing last 8 quarters.
Revenue by segment & region
By region
FY2025 · $1.28B total · annual
| Segment | Share | Revenue | YoY | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Europe Middle East And Africa | 53.9% | $690.3M | +3.4% | $634.0M | $667.8M | $690.3M |
| North America | 28.3% | $362.1M | +17.2% | $317.5M | $308.9M | $362.1M |
| Asia Pacific | 7.9% | $101.5M | +5.4% | $102.9M | $96.2M | $101.5M |
| ITALY | 7.3% | $93.3M | — | — | — | $93.3M |
| South America | 2.5% | $32.4M | +4.4% | $30.9M | $31.0M | $32.4M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.